Safety of Typhim Vi vaccine in a postmarketing observational study

Journal of Travel Medicine

Volumn 14, Issue 6, 2007, Pages 386-391

  Marcus, Leonard C ^a   Froeschle, James E ^b   Hill, David R ^c,d   Wolfe, Martin S ^e   Maus, Diane ^b   Connor, Bradley ^f   Acosta, Alberto M ^e   Rensimer, Edward R ^g   Roberts, Alan ^h   Dardick, Kenneth ⁱ  

^a Travelers' Hlth Immunization Serv   (United States)

^b SANOFI PASTEUR   (France)

^c National Travel Health Network and Centre   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e Traveler's Medical Service   (United States)

^f Travel Health Services   (United States)

^g Veterinary Internal Medicine   (United States)

^h Sunshine Medical Center South   (United States)

ⁱ Sunshine Medical Center South ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; DIPHENHYDRAMINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS TOXOID; ENCEPHALITIS VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; LYME DISEASE VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; RABIES VACCINE; TYPHOID VACCINE; YELLOW FEVER VACCINE;

ADULT; AGED; ALLERGIC URTICARIA; ANXIETY; ARTHRALGIA; ARTICLE; CHEST TIGHTNESS; CHILL; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; DIZZINESS; DRUG ERUPTION; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG TOLERABILITY; FACE EDEMA; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; IMMUNOGENICITY; INFECTION PREVENTION; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE REACTION; INSOMNIA; LEG CRAMP; MAJOR CLINICAL STUDY; MALAISE; MALE; MEDICAL INFORMATION; MYALGIA; NAUSEA; RESPIRATORY TRACT INFECTION; SALMONELLA ENTERICA; SALMONELLA TYPHI; SEROTYPE; SIDE EFFECT; SLEEP DEPRIVATION; TOOTH DISEASE; TRAVEL; TYPHOID FEVER; VERRUCA VULGARIS; WHEEZING;

ADOLESCENT; ADULT; AGED; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; POLYSACCHARIDES, BACTERIAL; PRODUCT SURVEILLANCE, POSTMARKETING; PROSPECTIVE STUDIES; SAFETY; TRAVEL; TYPHOID FEVER; TYPHOID-PARATYPHOID VACCINES; UNITED STATES;

EID: 35948999993     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2007.00158.x     Document Type: Article

References (15)

1. Parry CM, Hien TT, Dougan G, et al. Typhoid fever. N Engl J Med 2002 347 : 1770 1782.
2. Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bull World Health Organ 2004 82 : 346 353.
3. Centers for Disease Control and Prevention. Typhoid immunizations recommendations of the advisory committee on immunization practices (ACIP). MMWR 1994 43 : 1 7.
4. Spira AM. Preparing the traveller. Lancet 2003 361 : 1368 1381.
5. Lankester T. Health care of the long-term traveller. Travel Med Infect Dis 2005 3 : 143 155.
6. Centers for Disease Control and Prevention. Health Information for International Travel 2005-2006. Atlanta, GA : US Department of Health and Human Services, Public Health Service, 2005.
7. Steinberg EB, Bishop R, Haber P, et al. Typhoid fever in travelers: who should be targeted for prevention? CID 2004 39 : 186 191.
8. Acharya IL, Lowe CU, Thapa R, et al. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. N Engl J Med 1987 317 : 1101 1104.
9. Klugman KP, Gilbertson IT, Koornhof HJ, et al. Protective activity of Vi capsular polysaccharide vaccine against typhoid fever. Lancet 1987 1165 1169.
10. Yang J, Acosta CJ, Guoai S, et al. A mass vaccination campaign targeting adults and children to prevent typhoid fever in Hechi. BMC Public Health 2005 5 : 49.
11. Keitel WA, Bond NL, Zahradnik JM, et al. Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines. Vaccine 1994 12 : 195 199.
12. Plotkin SA, Bouveret-Le Cam N. A new typhoid vaccine composed of the Vi capsular polysaccharide. Arch Intern Med 1995 155 : 2293 2299.
13. Hessel L, Debois H, Fletcher M, et al. Experience with Salmonella typhi Vi capsular polysaccharide vaccine. Eur J Clin Microbiol Infect Dis 1999 18 : 609 620.
14. Aventis Pasteur. Typhim Vi polysaccharide vaccine. Prescribing Information. 2004.
15. Begier EM, Burwen DR, Haber P, et al. Postmarketing safety surveillance for typhoid fever vaccines from the vaccine adverse event reporting system, July 1990 through June 2002. CID 2004 38 : 771 779.